hepat
c
viru
hcv
small
envelop
viru
posit
strand
rna
genom
belong
flavivirida
famili
virion
uniqu
abil
form
complex
lipoprotein
known
lipoviroparticl
lipoprotein
compon
well
envelop
protein
play
key
role
viru
entri
hepatocyt
hcv
entri
complex
multistep
process
involv
sequenti
interact
sever
cell
surfac
protein
viru
reli
glycosaminoglycan
possibl
lowdens
lipoprotein
receptor
attach
cell
furthermor
four
specif
entri
factor
involv
follow
step
lead
viru
intern
fusion
earli
endosom
molecul
scaveng
receptor
tetraspanin
two
tight
junction
protein
occludin
although
essenti
hcv
entri
precis
role
molecul
complet
understood
final
hepatocyt
highli
polar
cell
like
affect
entri
process
current
knowledg
hcv
entri
summar
review
versita
sp
z
oo
hepat
c
global
health
problem
hepat
c
viru
hcv
infect
approxim
million
individu
worldwid
major
remain
undiagnos
untreat
infect
individu
viru
evad
immun
system
establish
chronic
infect
consequ
hepat
c
lead
caus
cirrhosi
endstag
liver
diseas
hepatocellular
carcinoma
liver
transplant
day
vaccin
avail
treatment
combin
pegyl
ribavirin
limit
efficaci
signific
side
effect
howev
specif
directact
antivir
proteas
polymeras
inhibitor
develop
two
proteas
inhibitor
alreadi
approv
use
usa
hcv
belong
genu
hepaciviru
flavivirida
famili
small
envelop
viru
posit
sens
singl
strand
rna
genom
kb
genom
translat
polyprotein
amino
acid
process
translat
cellular
viral
proteas
gener
structur
capsid
nonstructur
protein
structur
protein
compon
viral
particl
peculiar
featur
associ
lowor
lowdens
lipoprotein
ldl
vldl
mani
year
studi
hcv
life
cycl
impair
inabl
effici
grow
hcv
cell
cultur
howev
recent
year
sever
major
advanc
facilit
research
hcv
among
retrovir
particl
pseudotyp
hcv
envelop
glycoprotein
hcvpp
first
robust
vitro
assay
function
studi
hcv
entri
follow
major
breakthrough
hcv
research
develop
cell
cultur
system
allow
product
infecti
particl
hcvcc
hepatocyt
major
target
cell
hcv
infect
liver
complex
organ
contain
least
dozen
differ
cell
type
howev
liver
cell
popul
compos
hepatocyt
respons
major
liver
function
protein
synthesi
lipid
carbohydr
metabol
bile
synthesissecret
detoxif
function
capac
hepatocyt
express
specif
gene
function
requir
polar
separ
apic
basolater
membran
domain
differ
protein
lipid
composit
therefor
like
specif
architectur
liver
play
major
role
hcv
propag
within
organ
viral
entri
process
reli
fine
interplay
virion
host
cell
infect
initi
interact
viral
particl
specif
protein
cell
surfac
protein
belong
two
gener
categori
classifi
base
function
consequ
interact
attach
factor
receptor
attach
factor
serv
bind
concentr
particl
cell
surfac
usual
interact
rather
low
specif
hand
receptor
activ
promot
viru
entri
induc
conform
chang
viral
glycoprotein
andor
activ
signal
pathway
necessari
intern
virion
current
hcv
entri
view
complex
multistep
process
least
four
specif
cellular
factor
shown
essenti
hcv
entri
molecul
scaveng
receptor
class
b
type
tetraspanin
tight
junction
protein
occludin
ocln
review
review
first
address
know
composit
virion
may
signific
viral
entri
host
entri
factor
requir
hcv
entri
summar
current
knowledg
mechan
hcv
entri
hcv
rna
genom
core
envelop
glycoprotein
known
viral
compon
virion
hcv
genom
interact
core
form
nucleocapsid
surround
host
deriv
lipid
membran
call
viral
envelop
anchor
envelop
glycoprotein
hcv
envelop
glycoprotein
key
determin
hcv
entri
role
receptor
bind
mediat
fusion
process
viral
envelop
endosom
host
cell
membran
biogenesi
extens
character
recombin
system
heavili
nglycosyl
type
transmembran
protein
form
noncoval
heterodim
howev
recent
shown
hcv
envelop
glycoprotein
form
larg
coval
complex
stabil
disulfid
bond
secret
viral
particl
presenc
disulfid
bridg
hcv
envelop
glycoprotein
suggest
later
proteinprotein
interact
assist
disulfidebond
format
might
play
activ
role
bud
process
hcv
particl
furthermor
function
noninfecti
capsidless
structur
call
subvir
particl
produc
hcv
envelop
glycoprotein
express
alon
lipoprotein
produc
cell
line
support
idea
hcv
envelop
glycoprotein
play
activ
role
bud
process
secondari
tertiari
structur
envelop
glycoprotein
propos
similar
among
member
flavivirida
famili
suggest
hcv
envelop
glycoprotein
belong
class
ii
fusion
protein
recent
identif
intramolecular
disulfid
bond
solubl
shed
light
structur
compil
result
variou
data
relev
structur
function
krey
et
al
propos
model
tertiari
organ
consist
structur
class
ii
fusion
protein
figur
model
reveal
distribut
amino
acid
among
three
differ
domain
di
dii
diii
di
domain
consist
eight
bstrand
extend
nterminu
hypervari
region
domain
contain
determin
interact
recent
function
confirm
dii
domain
includ
hypervari
region
conserv
part
suggest
act
fusion
loop
aa
insert
target
membran
first
step
membran
fusion
di
connect
diii
domain
linker
region
call
intergenotyp
variabl
region
igvr
final
diii
connect
transmembran
domain
flexibl
stem
region
latter
region
potenti
involv
envelop
protein
heterodimer
well
viru
entri
amphipath
helix
like
fold
upon
membran
bind
identifi
ctermin
part
stem
region
propos
region
might
involv
reorgan
glycoprotein
complex
take
place
fusion
process
among
variabl
region
shown
essenti
interact
hcv
glycoprotein
known
hcv
receptor
although
attenu
phenotyp
virus
lack
remain
infecti
furthermor
propos
region
obstruct
viral
bind
site
well
conserv
neutral
epitop
potenti
play
role
aspect
hcv
immun
evas
surprisingli
nonconserv
region
like
igvr
essenti
assembl
function
heterodim
hcv
envelop
glycoprotein
contain
nglycosyl
site
respect
hcv
glycan
highli
conserv
tm
indic
cterminu
protein
posit
glycosyl
site
shown
ectodomain
glycoprotein
hypervari
region
intergenotyp
variabl
region
igvr
indic
furthermor
di
dii
diii
domain
stem
region
shown
red
yellow
blue
grey
respect
b
model
glycoprotein
linear
sequenc
ectodomain
strain
genbank
access
number
repres
chain
bead
color
circl
label
correspond
amino
acid
thread
onto
class
ii
fold
adapt
version
model
recent
publish
krey
et
al
doi
three
put
domain
present
red
di
yellow
dii
blue
diii
variabl
region
igvr
indic
brown
wherea
stem
region
shown
grey
circl
pale
bright
color
repres
residu
background
foreground
domain
respect
label
white
black
font
disulfid
bond
indic
black
bar
glycosyl
site
shown
green
circl
number
sequenti
di
domain
residu
particip
bind
contour
blue
shown
play
role
viru
assembl
entri
furthermor
form
glycan
shield
protect
viru
antibodi
neutral
hcv
virion
isol
patient
display
broad
rang
buoyant
densiti
associ
host
lipoprotein
antibodi
virion
lipoprotein
believ
form
complex
verylow
low
densiti
call
lipoviroparticl
exact
natur
hcv
associ
lipoprotein
remain
elus
yet
clearli
demonstr
infect
correl
viru
densiti
highest
infect
found
lowest
densiti
fraction
recent
character
cell
cultureproduc
particl
indic
composit
resembl
one
vldl
ldl
cholesteryl
ester
account
almost
half
total
hcv
lipid
thu
hcv
particl
possess
uniqu
lipid
composit
distinct
virus
analyz
far
importantli
chang
natur
hcvassoci
lipoprotein
lipoprotein
lipas
affect
hcv
infect
suggest
associ
hcv
specif
lipoprotein
import
infect
also
shown
hcv
assembl
pathway
depend
compon
vldl
synthesi
pathway
contribut
differ
vldl
pathway
compon
still
debat
group
found
apob
microsom
triglycerid
transfer
protein
major
contributor
other
indic
apo
play
predomin
role
explan
model
accommod
appar
conflict
data
recent
propos
apo
ligand
two
molecul
involv
hcv
infect
lowdens
lipoprotein
receptor
ldlr
antibodi
direct
apo
inhibit
hcv
infect
thu
support
role
apo
hcv
entri
furthermor
apo
isoform
associ
hcv
particl
shown
affect
level
viru
infect
apo
gene
inde
polymorph
differ
allel
lead
product
differ
isoform
isoform
show
differ
affin
ldlr
low
affin
receptor
infect
virion
produc
apo
knockdown
cell
could
properli
restor
express
poorli
among
apolipoprotein
anoth
factor
could
also
potenti
play
role
hcv
entri
major
receptor
highdens
lipoprotein
hdl
addit
ligand
report
includ
nativ
modifi
lipoprotein
modifi
serum
protein
receptor
play
crucial
role
select
lipid
uptak
bidirect
transfer
free
cholesterol
contain
two
membran
span
sequenc
flank
larg
nglycosyl
extracellular
loop
two
short
intracellular
domain
figur
role
hcv
entri
first
suggest
abil
mediat
solubl
bind
later
confirm
inhibit
hcv
infect
antibodi
silenc
protein
hepatoma
cell
review
residu
potenti
involv
glycoprotein
bind
recent
identifi
ectodomain
inde
amino
acid
residu
requir
recognit
altern
splice
transcript
lead
product
differ
ctermin
cytosol
domain
ctermin
domain
report
mediat
rapid
intern
intracellular
local
protein
cterminu
recent
shown
play
role
hcv
entri
delet
domain
introduct
endocytosi
motif
impair
hcv
entri
known
interact
cytoplasm
adaptor
molecul
via
akl
motif
ctermin
cytosol
tail
interact
involv
stabil
hepatocyt
recent
shown
play
indirect
role
hcv
entri
via
abil
interact
lead
enhanc
activ
hcv
entri
factor
ligand
known
affect
hcv
infect
review
notabl
hdl
enhanc
infect
acceler
viral
entri
mechan
depend
lipid
transfer
activ
also
presenc
suggest
interplay
occur
hcv
entri
also
possibl
lipid
transfer
chang
membran
lipid
composit
turn
may
affect
hcv
infect
addit
direct
bind
solubl
also
suggest
viru
bind
via
lipoprotein
compon
togeth
observ
interact
hcv
glycoprotein
role
lipid
metabol
suggest
entri
factor
may
play
dual
role
earli
step
hcv
life
cycl
recent
role
hcv
uptak
confirm
vivo
genet
human
mous
model
hcv
infect
member
tetraspanin
famili
like
member
famili
contain
transmembran
domain
small
sel
larg
extracellular
loop
lel
figur
tetraspanin
involv
mani
cell
function
adhes
morpholog
prolifer
differenti
enrich
specif
membran
microdomain
call
tetraspaninenrich
microdomain
tem
differ
convent
raft
domain
organ
depend
cholesterol
tetraspanin
interact
partner
protein
form
primari
complex
interact
togeth
form
network
interact
within
tem
role
hcv
entri
first
suggest
demonstr
interact
solubl
form
viru
intern
clathrinmedi
endocytosi
fuse
earli
endosom
deliv
nucleocapsid
cytosol
genom
viru
releas
translat
produc
structur
nonstructur
protein
nonstructur
protein
involv
viral
genom
replic
mechan
assembl
complet
understood
close
link
endoplasm
reticulum
er
lipid
droplet
ld
lipoproteinassoci
viru
releas
surround
medium
infect
new
cell
viru
also
transfer
directli
neighbor
cell
celltocel
transmiss
green
arrow
bc
bile
canaliculi
subsequ
extens
confirm
hcvpp
hcvcc
hcv
isol
patient
human
mous
model
review
bind
site
local
within
lel
character
chimer
protein
relat
tetraspanin
confirm
lel
sequenc
region
defin
hcv
entri
bind
site
map
variabl
doublehelix
subdomain
sever
studi
also
shown
cell
suscept
hcv
infect
close
relat
express
level
sinc
tetraspanin
molecul
known
interact
membran
protein
name
partner
involv
partner
modul
hcv
entri
investig
inde
gener
human
cell
line
express
murin
permiss
hcv
infect
allow
analysi
role
temassoci
hcv
infect
use
antibodi
recogn
temassoci
treatment
methylbcyclodextrin
sphingomyelinas
show
temassoci
preferenti
use
hcv
entri
hcv
entri
multisequenti
process
highli
dynam
associ
tem
may
lead
sequestr
tetraspanin
might
imped
interact
coreceptor
necessari
effici
hcv
entri
altern
tetraspanin
may
compet
coreceptor
interact
addit
lipid
composit
tem
might
suitabl
hcv
entri
studi
protein
led
identif
partner
block
bind
natur
inhibitor
produc
follow
cleavag
major
partner
express
cell
notabl
absent
hepatocyt
enabl
bind
allow
subsequ
infect
addit
presenc
specif
entri
factor
hepatotrop
might
partli
due
absenc
region
involv
interact
recent
identifi
shown
mutant
longer
interact
abl
exert
inhibitori
effect
hcv
infect
tight
junction
tj
membran
compon
special
seal
cell
doubl
function
control
paracellular
diffus
barrier
function
restrict
diffus
membran
protein
lipid
pole
fenc
function
electron
microscopi
tj
form
dens
structur
character
close
apposit
membran
neighbor
cell
cytosol
plaqu
inde
structur
compos
transmembran
protein
intracellular
molecul
transmembran
protein
play
import
role
seal
cell
interact
similar
molecul
either
ci
membran
cell
tran
membran
face
cell
tj
function
architectur
regul
signal
pathway
reli
tj
cytosol
plaqu
transmembran
protein
interact
adapt
cytosol
plaqu
link
surfac
protein
actin
cytoskeleton
ocln
two
transmembran
compon
tj
one
twenti
four
member
cldn
famili
evid
suggest
cldn
constitut
backbon
tight
junction
protein
consist
four
transmembran
domain
two
extracellular
loop
two
cytosol
domain
cterminu
contain
pdzbind
motif
bind
pdzcontain
plaqu
protein
zonula
occluden
zo
protein
figur
first
extracellular
loop
contain
conserv
glwxxc
c
motif
ocln
first
integr
tj
protein
identifi
protein
compos
four
transmembran
domain
two
extracellular
loop
short
ntermin
cytoplasm
domain
long
ctermin
one
figur
first
extracellular
loop
rich
glycin
tyrosin
residu
function
ocln
well
understood
may
particip
assembl
barrier
function
tj
recent
ocln
identifi
two
essenti
entri
factor
hcv
first
identifi
complementari
dna
librari
screen
gene
confer
hcvpp
suscept
cell
antibodi
direct
also
shown
inhibit
hcv
entri
two
member
cldn
famili
also
abl
render
cell
permiss
hcv
entri
first
extracellular
loop
shown
involv
hcv
entri
residu
import
hcv
infect
identifi
domain
figur
inde
mutat
residu
well
glwxxc
c
conserv
motif
affect
hcv
entri
furthermor
suggest
second
extracellular
loop
may
also
modul
function
hcv
entri
low
efficaci
mous
mediat
hcv
infect
link
three
amino
acid
residu
second
extracellular
loop
fourth
transmembran
helix
contrast
ctermin
domain
dispens
hcv
entri
ocln
last
entri
factor
identifi
probabl
involv
late
postbind
step
use
mous
human
ocln
chimera
speci
determin
hcv
entri
map
second
extracellular
loop
figur
furthermor
alaninescan
mutagenesi
two
ocln
extracellular
loop
reveal
second
part
second
loop
requir
hcv
entri
region
flank
two
cystein
mutat
abolish
hcv
infect
suggest
region
might
fold
disulfid
bond
ocln
express
hepatocyt
well
hcv
entri
increas
upon
glucocorticoid
treatment
contrast
ocln
express
downregul
upon
hcv
infect
probabl
prevent
superinfect
liver
hepatocyt
organ
plate
singl
cell
layer
separ
sinusoid
vessel
endotheli
cell
hepatocyt
separ
space
diss
drain
lymph
portal
tract
lymphat
figur
basolater
domain
hepatocyt
face
space
diss
wherea
apic
domain
form
tightli
close
space
call
canaliculi
bile
secret
tj
act
barrier
two
space
maintain
separ
membran
domain
maintain
distinct
molecular
composit
cell
polar
achiev
complex
regul
intracellular
traffick
deliv
newli
synthes
protein
suitabl
pole
believ
hcv
enter
liver
blood
flow
make
contact
hepatocyt
basolater
membran
order
infect
cell
propag
viru
need
overcom
complex
organ
hepatocyt
mechan
lead
hcv
entri
hepatocyt
still
poorli
understood
date
accumul
data
indic
hcv
entri
complex
multistep
process
involv
numer
compon
well
constraint
hepatocyt
polar
vivo
hcv
enter
liver
sinusoid
blood
gain
access
hepatocyt
viru
first
need
cross
sinusoid
endotheli
cell
barrier
ctype
lectin
propos
play
role
assist
viru
cross
liver
endothelium
review
howev
remain
demonstr
hcv
attach
hepatocyt
like
first
mediat
heparan
sulfat
proteoglycan
review
due
associ
virion
lipoprotein
ldlr
also
propos
play
role
earli
phase
hcv
entri
review
ldlr
mediat
intern
low
densiti
lipoprotein
releas
receptor
upon
ph
decreas
endosom
shown
hcv
infect
correl
ldlr
express
hepatocyt
inhibit
ldlr
ligand
therefor
possibl
lipoviroparticl
interact
ldlr
apob
andor
apo
compon
interact
like
modul
process
lvp
lpl
although
recent
data
favor
involv
ldlr
hcv
life
cycl
role
receptor
hcv
entri
remain
unclear
bind
cell
surfac
help
heparan
sulfat
proteoglycan
viru
interact
specif
entri
factor
evid
glycoprotein
interact
recent
propos
hcv
virion
first
interact
line
observ
hcv
virion
bind
cho
cell
express
cell
express
howev
remain
determin
whether
form
coreceptor
complex
whether
viru
transfer
current
evid
indic
hcv
particl
directli
interact
ocln
howev
shown
interact
fluoresc
reson
energi
transfer
fret
fluoresc
intens
ratio
fir
assay
suggest
may
partner
hcv
receptor
complex
concord
hypothesi
mutat
residu
first
extracellular
loop
prevent
hcv
entri
also
abolish
interact
furthermor
antibodi
direct
inhibit
hcv
entri
perturb
interact
recent
also
shown
epiderm
growth
factor
receptor
ephrin
receptor
act
host
cofactor
hcv
entri
regul
coreceptor
associ
analysi
interact
surfac
plasmon
reson
demonstr
specif
interact
lel
final
polar
cell
associ
occur
basolater
domain
cell
accord
viru
come
contact
hepatocyt
sinusoid
surfac
cell
although
also
interact
ocln
clear
relationship
associ
hcv
infect
initi
bind
attach
factor
prior
uptak
virus
move
later
cell
surfac
movement
allow
virus
interact
secondari
coreceptor
clathrinco
pit
singl
particl
imag
viral
entri
cell
reveal
hcv
particl
bind
cell
filopodia
reach
cell
bodi
mechan
reli
retrograd
actin
transport
cell
surfac
virion
interact
receptor
complex
andor
coreceptor
associ
clathrinco
pit
propos
may
play
role
transport
virion
basolater
face
cell
region
cellcel
contact
presum
tj
viru
could
interact
ocln
hypothesi
base
observ
solubl
form
glycoprotein
abl
induc
reloc
cell
cellcel
contact
area
coloc
ocln
transport
step
involv
actin
cytoskeleton
remodel
rhogtpas
activ
therefor
mediat
viru
bind
also
trigger
activ
signal
pathway
like
requir
viru
life
cycl
shown
hcv
undergo
clathrinmedi
endocytosi
fuse
earli
endosom
figur
hcv
intern
cell
slow
process
halfmaxim
intern
hcvpp
achiev
approxim
one
hour
sirna
librari
screen
led
identif
host
cofactor
involv
hcv
entri
protein
requir
hcv
infect
involv
clathrinmedi
endocytosi
well
actin
cytoskeleton
dynam
endosom
traffick
acidif
singl
particl
track
experi
surf
cell
surfac
virion
coloc
clathrin
ubiquitin
ligas
ccbl
exact
role
ccbl
hcv
entri
remain
elucid
yet
role
protein
clathrinmedi
endocytosi
alreadi
shown
bacteria
listeria
monocytogen
intern
viru
shown
transport
posit
earli
endosom
along
actin
stress
fiber
role
microtubul
hcv
infect
also
investig
use
pharmacolog
agent
known
affect
microtubul
vinblastin
nocodazol
paclitaxel
inhibit
hcv
infect
molecul
affect
hcv
entri
well
earli
postfus
step
gener
viru
endocytosi
mediat
receptor
howev
date
exact
role
hcv
coreceptor
endocytosi
viru
remain
undetermin
due
lack
robust
polar
hepatocyt
vitro
model
support
hcv
replic
role
tj
format
hcv
entri
remain
unclear
vivo
ocln
concentr
tj
wherea
cldn
also
detect
basolater
face
polar
cell
liver
tissu
though
viru
probabl
intern
tj
area
vivo
format
tj
dispens
hcv
entri
cell
cultur
data
suggest
nonjunct
pool
involv
hcv
entri
wherea
other
shown
local
cellcel
contact
requir
hcv
infect
addit
shown
nonpolar
cell
cell
densiti
format
cellcel
contact
modul
receptor
express
hcv
infect
precis
express
increas
confluent
cell
concentr
cellcel
contact
wherea
ocln
express
level
remain
unaffect
cell
confluenc
interestingli
infect
increas
confluent
cell
compar
subconflu
cell
cellcel
contact
promot
viru
intern
relev
cell
polar
hcv
entri
address
indirectli
use
hcvpp
system
cell
acquisit
polar
correl
reduct
hcvpp
entri
hcv
entri
also
studi
polar
cell
colorect
adenocarcinoma
cell
form
polar
monolay
cell
display
columnar
morpholog
apic
domain
basolater
domain
cell
poorli
permiss
hcvpp
infect
occur
apic
surfac
cell
suggest
tj
provid
barrier
viru
diffus
cell
receptor
express
increas
upon
cell
polar
polar
induc
reloc
apic
domain
tj
basal
domain
unpolar
cell
polar
cell
infect
similar
level
suggest
receptor
function
independ
tj
format
result
suggest
establish
cellcel
contact
polar
may
signific
hcv
entri
consequ
suitabl
model
polar
hepatoma
cell
line
much
need
studi
hcv
entri
model
also
use
understand
viru
spread
liver
base
observ
hcv
spread
cell
cultur
presenc
neutral
antibodi
mechan
direct
celltocel
hcv
transfer
propos
role
differ
hcv
coreceptor
transfer
investig
tj
protein
ocln
requir
howev
role
mechan
controversi
first
propos
hcv
celltocel
transmiss
occur
independ
antibodi
direct
unabl
inhibit
hcv
celltocel
transfer
transfer
cell
express
almost
undetect
level
observ
addit
model
upa
scid
mice
human
liver
meuleman
et
al
show
prophylact
treatment
antibodi
prevent
infect
postinfect
treatment
effect
result
suggest
viru
spread
may
howev
data
challeng
studi
celltocel
transmiss
abolish
cell
lack
treat
antibodi
compar
cellfre
infect
role
celltocel
transmiss
like
import
inde
neutral
effect
antibodi
specif
inhibitor
pronounc
infect
rout
addit
mutant
display
less
depend
demonstr
reduc
celltocel
transmiss
earli
endosom
fusion
viral
envelop
host
membran
occur
thu
allow
nucleocapsid
releas
cytosol
mechan
hcv
fusion
poorli
understood
fusion
viral
envelop
host
cell
membran
driven
viral
fusion
protein
undergo
major
conform
chang
fusion
trigger
differ
mechan
alon
combin
follow
receptor
bind
low
ph
exposur
proteolyt
process
hcv
believ
protein
mediat
fusion
hcvpp
entri
inhibit
neutral
endosom
ph
suggest
low
ph
exposur
requir
hcv
fusion
use
vitro
fusion
assay
virion
fluoresc
label
liposom
haid
et
al
report
fusion
trigger
low
ph
depend
viru
buoyant
densiti
lipid
composit
liposom
shown
viral
surfac
link
intermolecular
disulfid
bridg
larg
oligom
may
form
rigid
protein
lattic
may
consequ
fusion
process
class
ii
fusion
protein
undergo
oligomer
rearrang
fusion
process
lead
convers
trimer
like
disulfid
rearrang
requir
prime
hcv
fusion
process
critic
reshuffl
disulfid
bond
alreadi
shown
occur
virus
sindbi
viru
hiv
hiv
propos
protein
disulfid
isomeras
pdi
act
postbind
step
reduc
two
disulfid
bond
consequ
induc
fusion
compet
investig
potenti
role
pdi
disulfidebond
rearrang
hcv
envelop
protein
need
understand
fusion
process
develop
cell
cultur
system
propag
viru
consider
progress
made
understand
hcv
life
cycl
data
accumul
viru
indic
hcv
enter
host
cell
tightli
regul
complex
multistep
process
involv
presenc
sever
entri
factor
anoth
peculiar
hcv
hybrid
natur
lipoviroparticl
recent
progress
hcv
entri
highlight
contribut
hcv
envelop
glycoprotein
lipoprotein
moieti
virusassoci
lipoprotein
like
play
role
earli
phase
hcv
entri
wherea
envelop
glycoprotein
believ
take
lead
initi
step
howev
detail
success
event
occur
hcv
entri
remain
reveal
recent
structur
model
glycoprotein
provid
new
framework
better
understand
structurefunct
relationship
hcv
envelop
glycoprotein
lead
better
mechanist
understand
entri
process
spite
major
progress
field
still
unclear
viru
overcom
compact
highli
organ
environ
liver
role
tj
format
hcv
infect
remain
elucid
